Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127392331 | 12739233 | 1 | I | 201606 | 20160908 | 20160913 | 20160913 | EXP | CH-SM-2016-07246 | CH-ELI_LILLY_AND_COMPANY-CH201609004135 | ELI LILLY AND CO | 69.01 | YR | F | Y | 0.00000 | 20160913 | CN | CH | CH |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127392331 | 12739233 | 1 | PS | ZYPREXA | OLANZAPINE | 1 | Oral | 1 DF, UNKNOWN | Y | U | 20592 | 1 | DF | ||||||
| 127392331 | 12739233 | 2 | SS | HALDOL | HALOPERIDOL | 1 | Oral | 1 DF, UNKNOWN | Y | U | 0 | 1 | DF | ||||||
| 127392331 | 12739233 | 3 | SS | TEMESTA /00273201/ | LORAZEPAM | 1 | Oral | 1 DF, UNKNOWN | Y | U | 0 | 1 | DF | ||||||
| 127392331 | 12739233 | 4 | SS | SEROQUEL | QUETIAPINE FUMARATE | 1 | Oral | 62.5 MG, QD (INCREASED GRADUALLY TO 62.5 MG/D (12.5-25-25), WITHOUT BEING EFFECTIVE) | Y | U | 0 | 62.5 | MG | QD | |||||
| 127392331 | 12739233 | 5 | C | EBIXA | MEMANTINE HYDROCHLORIDE | 1 | Oral | 10 MG, BID | 0 | 10 | MG | BID | |||||||
| 127392331 | 12739233 | 6 | C | REMERON | MIRTAZAPINE | 1 | Oral | UNK | Y | 0 | |||||||||
| 127392331 | 12739233 | 7 | C | TRITTICO | TRAZODONE HYDROCHLORIDE | 1 | Oral | 50 MG, QD | Y | 0 | 50 | MG | QD | ||||||
| 127392331 | 12739233 | 8 | C | LYRICA | PREGABALIN | 1 | Oral | 75 MG, BID | Y | 0 | 75 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127392331 | 12739233 | 1 | Agitation |
| 127392331 | 12739233 | 2 | Agitation |
| 127392331 | 12739233 | 3 | Agitation |
| 127392331 | 12739233 | 4 | Agitation |
| 127392331 | 12739233 | 5 | Dementia Alzheimer's type |
| 127392331 | 12739233 | 6 | Product used for unknown indication |
| 127392331 | 12739233 | 7 | Product used for unknown indication |
| 127392331 | 12739233 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127392331 | 12739233 | HO |
| 127392331 | 12739233 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127392331 | 12739233 | Abnormal behaviour | |
| 127392331 | 12739233 | Agitation | |
| 127392331 | 12739233 | Akathisia | |
| 127392331 | 12739233 | Condition aggravated | |
| 127392331 | 12739233 | Dementia Alzheimer's type | |
| 127392331 | 12739233 | Dysphagia | |
| 127392331 | 12739233 | Epilepsy | |
| 127392331 | 12739233 | Fall | |
| 127392331 | 12739233 | Hallucinations, mixed | |
| 127392331 | 12739233 | Muscle rigidity | |
| 127392331 | 12739233 | Restlessness |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127392331 | 12739233 | 1 | 20160707 | 20160718 | 0 | |
| 127392331 | 12739233 | 2 | 201512 | 20160706 | 0 | |
| 127392331 | 12739233 | 3 | 20160707 | 20160718 | 0 | |
| 127392331 | 12739233 | 4 | 20160727 | 20160819 | 0 | |
| 127392331 | 12739233 | 5 | 2014 | 0 | ||
| 127392331 | 12739233 | 6 | 20160808 | 20160815 | 0 | |
| 127392331 | 12739233 | 7 | 20160816 | 20160819 | 0 | |
| 127392331 | 12739233 | 8 | 20160817 | 20160819 | 0 |